Automatic translation by Google. Limitations and info.

Early February, during the 158th session of the WHO Executive Board, Member States were expected to adopt an updated version of the Global Action Plan on Antimicrobial Resistance, but the process hit a deadlock over the proposed language on technology transfer. Negotiations will be reopened on limited parts of the text ahead of the World Health Assembly in May.

More than 35,000 people die each year in the EU/EEA as a result of infections caused by antibiotic-resistant bacteria, highlighting a growing threat that reflects global trends.
In this context, the EU Joint Action on Antimicrobial Resistance (EU JAMRAI 2) held a meeting at the end of January, bringing together representatives from EU Member States, Norway, Iceland, Ukraine, and more than 130 partner organizations worldwide.
Click to read reflections from Anna Sjöblom, Director ReAct Europe, who participated in the meeting days.

From January 26 to 29, the final global convening of the “Just Transitions for AMR” group took place at the Tropical Agricultural Research and Higher Education Centre (CATIE) in Costa Rica. This international event was organized within the framework of the British Academy’s Global Convening Program 2026, in coordination with the University of Oxford.
ReAct Latin America contributed with community-led solutions to the meeting.

Although global policy commitments and technical knowledge have expanded significantly, a persistent gap remains between political declarations and effective implementation. Bridging this gap requires sustained platforms that enable interdisciplinary dialogue, knowledge exchange, and collaborative governance across sectors and regions.
In this context, ReAct Asia Pacific organized a regional meeting September 2025, now you can learn more about the days and access the meeting report.

A new policy brief launched during a High-Level global dialogue underscores the indispensable role of faith-based organizations in addressing antimicrobial resistance, one of the most urgent and complex public health threats of our time. Convened by the World Council of Churches, the dialogue brought together global health leaders, policymakers, and faith actors to explore how trusted community institutions can help strengthen AMR prevention, stewardship, and advocacy – particularly across Africa.

As we mark World Cancer Day 2026 under the theme “United by Unique” we must confront an often-overlooked but critical threat to cancer care: antibiotic resistance. While global efforts rightly focus on expanding access to early diagnosis, treatment, and palliative care, the silent crisis of antibiotic resistance is undermining the very foundation of modern oncology. For millions of cancer patients worldwide—especially those undergoing chemotherapy, surgery, or stem cell transplants—effective antibiotics are not just supportive care; they are lifesaving.

Antibiotic resistance is one of the most pressing public health threats facing Africa today. Its drivers including misuse of antibiotics, self-medication, and improper disposal of medicines are deeply rooted in community practices. This makes community engagement essential. Faith-Based Organisations (FBOs), among the most trusted and far-reaching institutions across the continent, are uniquely positioned to influence behaviours, shape values, and extend health messages into households and communities that formal health systems may not consistently reach. Engaging faith leaders therefore strengthens public understanding of AMR and supports lasting behaviour change.

On 28 December 2025, India’s Prime Minister Narendra Modi used his ‘Mann Ki Baat’ (Speaking my Mind) broadcast to reach millions of Indian households to deliver a direct public message on antimicrobial resistance. Drawing on evidence from the Indian Council of Medical Research (ICMR), he cautioned citizens against “mindless” self-medication with antibiotics and emphasized that these medicines should only be taken on a doctor’s advice. By citing specific ICMR data through a platform known for its personal, conversational tone, Prime Minister Modi shifted antimicrobial resistance from the confines of microbiology laboratories and policy documents into public consciousness – a turning point that has positioned antibiotic stewardship as both a personal and collective responsibility.

Antibiotic resistance is a growing, cross-sectoral challenge that risks derailing progress across the Sustainable Development Goals. To help bridge policy silos and advance more coherent responses, ReAct Europe is leading a new project within Uppsala University’s newly established interdisciplinary research institute, UUniCORN. The BRIDGE-ABR project brings together researchers and practitioners to identify policy goal conflicts and generate integrated solutions that strengthen both antibiotic resistance mitigation and sustainable development outcomes.

ReAct Latin America celebrated the ReAct network’s twentieth anniversary with a regional commemorative anthology that brings together almost two decades of participatory research-action addressing antibiotic resistance in Latin America. The regional anthology includes materials, approaches, and methodologies collaboratively developed with diverse social and academic sectors, with the aim of fostering new paradigms, actions, policies, and practices based on the advances, lessons learned, and ongoing challenges of this global health issue. For the release many collaborators from the region was invited to celebrate.